Chu Nimes/Institut De Cancerologie Du Gard

Nîmes, Nimes 30900

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling